Update: The diagnosis and management of dengue virus infection in North America

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 3, 2012, Pages 215-220

  Wright, William F ^a   Pritt, Bobbi S ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Dengue diagnostics; Dengue Fever; Dengue hemorrhagic fever; Dengue shock syndrome; Dengue virus

Indexed keywords

CHLOROQUINE; DENGUE VACCINE; DEXAMETHASONE; DEXTRAN; FRESH FROZEN PLASMA; INTERFERON; METHYLPREDNISOLONE; RHESUS D ANTIBODY; RIBAVIRIN; RINGER LACTATE SOLUTION; STARCH; TYPHIN VI; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIBODY DETECTION; ANTIVIRAL ACTIVITY; ASTHENIA; CLINICAL FEATURE; DENGUE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FLUID RESUSCITATION; HUMAN; IMMUNOASSAY; INJECTION SITE PAIN; LABORATORY TEST; LATERAL FLOW IMMUNOCHROMATOGRAPHY ASSAY; LOW DRUG DOSE; MALAISE; MOLECULAR DIAGNOSIS; MORBIDITY; MORTALITY; MOSQUITO; MYALGIA; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SERODIAGNOSIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRAVEL; TREATMENT PLANNING; UNITED STATES; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION; VOMITING; WORLD HEALTH ORGANIZATION;

CLINICAL LABORATORY TECHNIQUES; DENGUE; DENGUE VIRUS; HUMANS; IMMUNOASSAY; INCIDENCE; MOLECULAR DIAGNOSTIC TECHNIQUES; UNITED STATES;

EID: 84862209953     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.03.021     Document Type: Review

References (44)

1. Bessoff K., Delorey M., Sun W., Hunsperger E. Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for the diagnosis of acute DENV infection. Clin Vaccine Immunol 2008, 15:1513-1518.
2. Balmaseda A., Guzman M.G., Hammond S., Robleto G., Flores C., Tellez Y., et al. Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol 2003, 10:317-322.
3. Blacksell S.D., Doust J.A., Newton P.N., Peacock S.J., Day N.P., Dondorp A.M. A systematic review and meta-analysis of the diagnostic accuracy of rapid immunochromatographic assays for the detection of dengue virus IgM antibodies during acute infection. Trans R Soc Trop Med Hyg 2006, 100:775-784.
4. Blacksell S.D., Newton P.N., Bell D., Kelley J., Mammen M.P., Vaughn D.W., et al. The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection. Clin InfectDis42 2006, 1127-1134.
5. Capeding R.Z., Luna I.A., Bomasang E., Lupisan S., Lang J., Forrat R., et al. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines. Vaccine 2011, 29:3863-3872.
6. Centers for Disease Control and Prevention (CDC) Dengue hemorrhagic fever-U.S.-Mexico border, 2005. MMWR Morb Mortal Wkly Rep 2007, 56:785-789.
7. Centers for Disease Control and Prevention (CDC) Locally acquired Dengue-Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 2010, 59:577-581.
8. Crance J.M., Scaramozzino N., Jouan A., Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 2003, 58(1):73-79.
9. de Castro R.A., de Castro J.A., Barez M.Y., Frias M.V., Dixit J., Genereux M. Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (RH(0)-D) immune globulin. Am J Trop Med Hyg 2007, 76:737-742.
10. de Oliveira Poersch C., Pavoni D.P., Queiroz M.H., de Borba L., Goldenberg S., dos Santos C.N., et al. Dengue virus infections: comparison of methods for diagnosing the acute disease. J ClinVirol 2005, 32:272-277.
11. DengueMap. A CDC-HealthMap Collaboration. 2/8/2012. HealthMap. 2012. Accessed on 2/26/2012. Available at: http://www.healthmap.org/dengue.
12. De Paula S.O., Fonseca B.A. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 2004, 8:390-398.
13. Effler P.V., Pang L., Kitsutani P., Vorndam V., Nakata M., Ayers T., Hawaii Dengue Outbreak Investigation Team, et al. Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis 2005, 11:742-749.
14. Fry S.R., Meyer M., Semple M.G., Simmons C.P., Sekaran S.D., Huang J.X., et al. The diagnostic sensitivity of dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach. PLoS Negl Trop Dis 2011, 5:e1199.
15. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010, 8(12 Suppl):S7-16.
16. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
17. Hammond S.N., Balmaseda A., Perez L., Tellez Y., Saborio S.I., Mercado J.C., et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 2005, 73:1063-1070.
18. Hunsperger E.A., Yoksan S., Buchy P., Nguyen V.C., Sekaran S.D., Enria D.A., et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis 2009, 15:436-440.
19. Innis B.L., Nisalak A., Nimmannitya S., Kusalerdchariya S., Chongswasdi V., Suntayakorn S., et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989, 40:418-427.
20. Johnson B.W., Russell B.J., Lanciotti R.S. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol 2005, 43:4977-4983.
21. Kularatne S.A., Walathrara C., Mahindawansa S.I., Wijesinghe S., Pathirage M.M., Kumarasiri P.V., et al. Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study. Postgrad Med J 2009, 85:525-529.
22. Kumarasamy V., Wahab A.H., Chua S.K., Hassan Z., Chem Y.K., Mohamad M., et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods 2007, 140:75-79.
23. Kuno G., Gubler D.J., Velez M., Oliver A. Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. Bull World Health Organ 1985, 63:279-286.
24. López Izquierdo, N. Re-infestation by Aedes aegypti. From the collection: Assorted illustrations for the Arctic Council. Global Environment Outlook GEO 4: Environment for development. UNEP/GRID-Arendal 2007. Accessed on 2/26/2012.
25. Lye D.C., Lee V.J., Sun Y., Leo Y.S. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. Clin Infect Dis 2009, 48:1262-1265.
26. Mohammed H., Ramos M., Armstrong J., Munoz-Jordan J., Arnold-Lewis K.O., Ayala A., et al. An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005. PLoS One 2010, e13729:5.
27. Mohammed H.P., Ramos M.M., Rivera A., Johansson M., Munoz-Jordan J.L., Sun W., et al. Travel-associated dengue infections in the United States, 1996 to 2005. J Travel Med 2010, 17:8-14.
28. Morita K., Tanaka M., Igarashi A. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol 1991, 29:2107-2110.
29. Morrison D., Legg T.J., Billings C.W., Forrat R., Yoksan S., Lang J. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naïve adults. J Infect Dis 2010, 201:370-377.
30. Najioullah F., Combet E., Paturel L., Martial J., Koulmann L., Thomas L., et al. Prospective evaluation of nonstructural 1 enzyme-linked immunosorbent assay and rapid immunochromatographic tests to detect dengue virus in patients with acute febrile illness. Diagn Microbiol Infect Dis 2011, 69:172-178.
31. Parola P., de Lamballerie X., Jourdan J., Rovery C., Vaillant V., Minodier P., et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 2006, 12:1493-1499.
32. Raengsakulrach B., Nisalak A., Maneekarn N., Yenchitsomanus P.T., Limsomwong C., Jairungsri A., et al. Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. J Virol Methods 2002, 105:219-232.
33. Ranjit S., Kissoon N., Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. PediatrCrit Care Med 2005, 6:412-419.
34. Schwartz E., Weld L.H., Wilder-Smith A., von Sonnenburg F., Keystone J.S., Kain K.C., et al. Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis 2008, 14:1081-1088.
35. Sellahewa K.H., Samaraweera N., Thusita K.P., Fernando J.L. Is fresh frozen plasma effective for thrombocytopenia in adults with dengue fever? A prospective randomized double blind controlled study. Ceylon Med J 2008, 53:36-40.
36. Shu P.Y., Huange J.H. Current advances in dengue diagnosis. Clin Diagn Lab Immunol 2004, 11:642-650.
37. Tassniyom S., Vasanawathana S., Chirawatkul A., Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993, 92:111-115.
38. Thai K.T., Phuong H.L., ThanhNga T.T., Giao P.T., Hung Ie Q., Van Nam N., et al. Clinical, epidemiological and virological features of dengue virus infections in Vietnamese patients presenting to primary care facilities with acute undifferentiated fever. J Infect 2010, 60:229-237.
39. Tricou V., Minh N.N., Van T.P., Lee S.J., Farrar J., Wills B., et al. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 2010, 4:e785.
40. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000, 181:2-9.
41. Vaughn D.W., Nisalak A., Kalayanarooj S., Solomon T., Dung N.M., Cuzzubbo A., et al. Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol 1998, 36:234-238.
42. Wills B.A., Nguyen M.D., Ha T.L., Dong T.H., Tran T.N., Le T.T., et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005, 353:877-889.
43. World Health Organization (WHO) Dengue guidelines for diagnosis, treatment, prevention, and control 2009, 1-147. World Health Organization, Geneva, Switzerland. 3rd ed.
44. Yong Y.K., Thayan R., Chong H.T., Tan C.T., Sekaran S.D. Rapid detection and serotyping of dengue virus by multiplex RT-PCR and real-time SYBR green RT-PCR. Singapore Med J 2007, 48:662-668.